Surgery Partners, Inc. (SGRY) News
Filter SGRY News Items
SGRY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SGRY News Highlights
- For SGRY, its 30 day story count is now at 10.
- Over the past 14 days, the trend for SGRY's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- NOV, ARVN and BGNE are the most mentioned tickers in articles about SGRY.
Latest SGRY News From Around the Web
Below are the latest news stories about SURGERY PARTNERS INC that investors may wish to consider to help them evaluate SGRY as an investment opportunity.
Analysts Offer Insights on Healthcare Companies: Agilent (A), Surgery Partners (SGRY) and Arvinas Holding Company (ARVN)There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Agilent (A – Research Report), Surgery Partners (SGRY – Research Report) and Arvinas Holding Company (ARVN – Research Report) with bullish sentiments. Agilent (A) In a report released today, Puneet Souda from SVB Securities maintained a Buy rating on Agilent, with a price target of $160.00. The company's shares closed last Monday at $145.14. According to TipRanks. |
Surgery Partners, Inc. Announces Pricing of Upsized $575 Million Public Offering of Common Stock and $225 Million Concurrent Private Placement to Bain CapitalBRENTWOOD, Tenn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its upsized underwritten public offering of $575 million of its common stock at a public offering price of $24.50 per share. Gross proceeds to Surgery Partners from the offering are expected to be approximately $575 million, before deducting underwriting discounts and commissions and other offering expenses payable by Surgery Partners. In addition, Surgery |
Surgery Partners stock falls after public stock offering of $275 million, private placement of $225 mlnShares of Surgery Partners Inc. shed 2.6% in premarket trading Monday, after the outpatient health care services company said it launched a public offering of $275 million worth of its common stock. The offering represents 11.2% of the market capitalization of $2.45 billion as of Friday's close. Separately, an affiliate of Bain Capital, which is the largest shareholder owning about 54.5% of the shares outstanding, according to FactSet data, has agreed to buy $225 million worth of common stock in |
Surgery Partners, Inc. Announces Proposed Public Offering of Common StockBRENTWOOD, Tenn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of $275 million of its common stock. All of the shares to be sold in the offering are to be sold by Surgery Partners. In connection with the offering, Surgery Partners intends to grant the underwriters a 30-day option to purchase up to $41.25 million of additional shares of its common stock. The offering is subject to |
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surgery Partners (SGRY), BeiGene (BGNE) and Genmab (GMAB)Analysts have been eager to weigh in on the Healthcare sector with new ratings on Surgery Partners (SGRY – Research Report), BeiGene (BGNE – Research Report) and Genmab (GMAB – Research Report). Surgery Partners (SGRY) In a report released today, Whit Mayo from SVB Securities maintained a Buy rating on Surgery Partners, with a price target of $55.00. The company's shares closed last Wednesday at $22.30, close to its 52-week low of $20.46. According to TipRanks. |
Surgery Partners Third Quarter 2022 Earnings: Misses ExpectationsSurgery Partners ( NASDAQ:SGRY ) Third Quarter 2022 Results Key Financial Results Revenue: US$620.6m (up 11% from 3Q... |
Surgery Partners (SGRY) Stock Dropped in the Third QuarterClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark, the Russell 3000 Index, in the third quarter. The strategy’s outperformance in the quarter was attributed to contributions from several smaller-cap, growth-oriented businesses in the consumer […] |
Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 33% Below Their Intrinsic Value EstimateIn this article we are going to estimate the intrinsic value of Surgery Partners, Inc. ( NASDAQ:SGRY ) by projecting... |
Surgery Partners (SGRY) Reports Q3 Loss, Lags Revenue EstimatesSurgery Partners (SGRY) delivered earnings and revenue surprises of -150% and 0.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? |
Surgery Partners, Inc. Announces Third Quarter 2022 ResultsBRENTWOOD, Tenn., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the third quarter ended September 30, 2022. Revenue increased 11.0% from the prior year period to $620.6 million with same-facility revenues increasing 5.1% Net loss attributable to common stockholders was $25.0 million, with Adjusted EBITDA of $96.2 million; nearly 26% greater than the prior year peri |